SB0422In Committee

Amends TCA Title 8; Title 47; Title 56; Title 63 and Title 71.

Tennessee SB0422 amends the review timeline for an advisory committee, composed of medical device industry representatives and a representative from the Department of Economic and Community Development, from every three years to every two years. This change affects the oversight of facilities that manufacture, warehouse, and distribute medical devices by the Board of Pharmacy. The key provision is the reduction of the review period for advancements in new medical device technologies.

What moved, what's on next week's agenda, new filings — every Monday, from the public record, free.

No account. Unsubscribe in one click.

Overview

Tennessee SB0422 amends the review timeline for an advisory committee, composed of medical device industry representatives and a representative from the Department of Economic and Community Development, from every three years to every two years. This change affects the oversight of facilities that manufacture, warehouse, and distribute medical devices by the Board of Pharmacy. The key provision is the reduction of the review period for advancements in new medical device technologies.

Track Tennessee Legislation Like a Pro

Join hundreds of professionals using LegisGo to stay ahead of legislative changes.

Instant Alerts

Get notified when bills you track move through the legislature

AI Summaries

Understand complex legislation in seconds with AI-powered analysis

Full Access

All 132 legislators, committee schedules, and voting records

Sponsor

Reeves, Shane

Details
Session

114th General Assembly

Introduced

January 28, 2025

Last Action

April 20, 2026

Placed on Senate Finance, Ways, and Means Committee calendar for 4/21/2026

Subjects
Health Care

Want to track this bill? Get instant alerts and AI-powered insights.